Diagnosis and treatment of acromegaly complications

[1]  D. Lüdecke,et al.  Acromegaly and hypertension: Prevalence and relationship to the renin-angiotensin-aldosterone system , 1990, Klinische Wochenschrift.

[2]  S. Melmed,et al.  Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly. , 2003, The Journal of clinical endocrinology and metabolism.

[3]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[4]  P. Chanson,et al.  Guidelines for acromegaly management. , 2002, The Journal of clinical endocrinology and metabolism.

[5]  Paolo Cappabianca,et al.  Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. , 2002, Journal of neurosurgery.

[6]  P. Freda.  Somatostatin analogs in acromegaly. , 2002, The Journal of clinical endocrinology and metabolism.

[7]  C. Ronchi,et al.  Effects of two different somatostatin analogs on glucose tolerance in acromegaly , 2002, Journal of endocrinological investigation.

[8]  G. Meno-Tetang,et al.  SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. , 2002, European journal of endocrinology.

[9]  F. Di Salle,et al.  Long‐term effects of lanreotide SR and octreotide LAR® on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly , 2002, Clinical endocrinology.

[10]  J. A. Scarlett,et al.  Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist , 2001, The Lancet.

[11]  D. Kleinberg,et al.  Rheumatic manifestations of pituitary tumors , 2001, Current rheumatology reports.

[12]  S. Melmed.  CLINICAL PERSPECTIVE: Acromegaly and Cancer: Not a Problem? , 2001 .

[13]  P. Jenkins,et al.  Clinical perspective: acromegaly and cancer: a problem. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  E. Laws,et al.  Conventional radiotherapy for pituitary tumors. , 2000, Neurosurgery clinics of North America.

[15]  A. Renehan,et al.  The prevalence and characteristics of colorectal neoplasia in acromegaly. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  R. Reznek,et al.  The Pathology of Median Neuropathy in Acromegaly , 2000, Annals of Internal Medicine.

[17]  H. Lochs,et al.  Diabetes‐Häufigkeit bei Akromegalie und Cushing‐Syndrom , 2000 .

[18]  G. Papi,et al.  Baseline and stimulated catecholamine secretion in normotensive patients with active acromegaly: acute effects of continuous octreotide infusion. , 2000, European journal of endocrinology.

[19]  F. Casanueva,et al.  Criteria for cure of acromegaly: a consensus statement. , 2000, The Journal of clinical endocrinology and metabolism.

[20]  S. Melmed,et al.  Pituitary tumor registry: a novel clinical resource. , 2000, The Journal of clinical endocrinology and metabolism.

[21]  A. Renehan,et al.  Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3 , 1999 .

[22]  P. Stewart,et al.  Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon. , 1999, QJM : monthly journal of the Association of Physicians.

[23]  M. Salvatore,et al.  Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. , 1999, The Journal of clinical endocrinology and metabolism.

[24]  A. Simon,et al.  Decreased regional blood flow in patients with acromegaly , 1998, Clinical endocrinology.

[25]  S. Melmed.  Tight control of growth hormone: an attainable outcome for acromegaly treatment. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  P. Black,et al.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. , 1998, The Journal of clinical endocrinology and metabolism.

[27]  R. McNally,et al.  Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study , 1998 .

[28]  A. Gulino,et al.  Prevalence of hypertension in acromegalic patients: clinical measurement versus 24‐hour ambulatory blood pressure monitoring , 1998, Clinical endocrinology.

[29]  V. Marks,et al.  Hyperproinsulinaemia in Acromegaly: Evidence for Abnormal Pancreatic β-Cell Function? , 1997, Annals of clinical biochemistry.

[30]  S. Melmed,et al.  Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. , 1997, The Journal of clinical investigation.

[31]  P. Newcomb,et al.  Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner* , 1997, The Journal of Biological Chemistry.

[32]  P. Cappabianca,et al.  Effect of octreotide pretreatment on surgical outcome in acromegaly. , 1997, The Journal of clinical endocrinology and metabolism.

[33]  G. Romanelli,et al.  Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. , 1995, The American journal of cardiology.

[34]  O. Wiklund,et al.  Serum lipoproteins in acromegaly before and 6‐15 months after transsphenoidal adenomectomy , 1994, Clinical endocrinology.

[35]  A. Bankier,et al.  [Bone density of the lumbar spine and femur in acromegaly]. , 1993, Der Radiologe.

[36]  D. Chisholm,et al.  Impact of octreotide, a long‐acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly , 1992, Clinical endocrinology.

[37]  C. Sullivan,et al.  Sleep apnea in acromegaly. , 1991, Annals of internal medicine.

[38]  J. Hughes,et al.  Upper airflow obstruction and pulmonary function in acromegaly: relationship to disease activity. , 1991, The Quarterly journal of medicine.

[39]  S. Posen,et al.  Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. , 1989, Annals of internal medicine.